News
-
Mice born with Fragile X syndrome have fewer cell antennasStructures called primary cilia - which act like TV antennas for cells to detect signals - are present in fewer numbers in mice born with Fragile X syndrome, according to researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio). Study results were published July 30 in the journal Stem Cell Reports.More details
-
MicroRNA shows promise for hair regrowth
Researchers from North Carolina State University have identified a microRNA (miRNA) that could promote hair regeneration. This miRNA -- miR-218-5p -- plays an important role in regulating the pathway involved in follicle regeneration, and could be a candidate for future drug development.
-
Continuous survival of neurons is intrinsically programmed during development
When our neurons -- the principle cells of the brain -- die, so do we.
-
RUSSIAN GENETICS PRESENTED THE FIRST RESULTS OF PILOT SCREENING PROGRAMS FOR SPINAL MUSCULAR ATROPHYThe first program supported by ROSH is newborn screening, which involves three leading perinatal centers in Moscow. The second program is selective screening of patients with suspected SMA from all regions of Russia.More details
-
THE DECLARATION ON ETHICAL PRINCIPLES OF PROVIDING SERVICES TO PEOPLE WITH MENTAL SPECIALTIES CREATED BY EMPLOYEES OF THE LOVE SYNDROME AND DOWNSIDE UP FOUNDATIONS“Perhaps in 100 or even 10 years these principles will be completely obvious to all citizens. But today they need our common support - as well as those people for whose benefit they are directed ”, - this is how the authors explain the idea of creating the document.More details
-
RUSSIAN GENETICS PROPOSED A METHOD FOR PREDICTION OF THE EFFECTIVENESS OF PREOPERATIVE CHEMOTHERAPY FOR LUMINAL-SUBTYPE BREAST CANCERPre-treatment (neoadjuvant) chemotherapy is given to reduce the volume of the tumor, which will further reduce the amount of surgery. However, today in 30-60% of cases, preoperative chemotherapy does not bring the expected effect, the reason is that oncologists do not have reliable tools for predicting its effectiveness.More details
Thanks for subscribing!